Equity Analysis /
United States of America

US : Sage Therapeutics, Inc. - SAGE | Takeaways From SAGE-718 Deep-Dive: Promising But More Data Needed To Really Pique Interest

    Danielle Brill
    Daniil Gataulin
    Daniil Gataulin

    Ph.D., Sr. Res. Assoc.

    CGS-CIMB
    20 May 2021
    Published by